The financing secures funds to advance the clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology
This deal makes Meddo, one of the largest health-tech players in India
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline
Subscribe To Our Newsletter & Stay Updated
